Cdt1 Is Differentially Targeted for Degradation by Anticancer Chemotherapeutic Drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cdt1 Is Differentially Targeted for Degradation by Anticancer Chemotherapeutic Drugs

Published:2012-03-30 Issue:3 Volume:7 Page:e34621
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Stathopoulou Athanasia,Roukos Vassilis,Petropoulou Chariklia,Kotsantis Panagiotis,Karantzelis Nickolas,Nishitani Hideo,Lygerou Zoi,Taraviras Stavros

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference51 articles.

1. XCDT1 is required for the assembly of pre-replicative complexes in Xenopus laevis.;D Maiorano;Nature,2000

2. The Cdt1 protein is required to license DNA for replication in fission yeast.;H Nishitani;Nature,2000

3. Chromatin unfolding by Cdt1 regulates MCM loading via opposing functions of HBO1 and HDAC11-geminin.;PG Wong;Cell Cycle,2010

4. The human licensing factor for DNA replication Cdt1 accumulates in G1 and is destabilized after initiation of S-phase.;H Nishitani;J Biol Chem,2001

5. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression.;A Sakaue-Sawano;Cell,2008

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDT1, transcriptionally regulated by E2F2, promotes lung adenocarcinoma progression;Heliyon;2024-08

2. CDT1 drives replication overlicensing and enhances tumorigenesis in the gut ^†;The Journal of Pathology;2023-01-25

3. Intrinsic neural stem cell properties define brain hypersensitivity to genotoxic stress;Stem Cell Reports;2022-06

4. Small Molecule Inhibitor Targeting CDT1/Geminin Protein Complex Promotes DNA Damage and Cell Death in Cancer Cells;Frontiers in Pharmacology;2022-04-25

5. SIRT3 promotion reduces resistance to cisplatin in lung cancer by modulating the FOXO3/CDT1 axis;Cancer Medicine;2021-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3